Showing results (11-20 of 499) with videos related to
Sort By:
Pageof 50
Vaccine|May 26, 2009
Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patientsBénédicte Puissant-Lubrano, Béhazine Combadière, Darragh Duffy, et al.BMC Infectious Diseases|March 5, 2014
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational studySuhaib Hattab, Amelie Guihot, Marguerite Guiguet, et al.AIDS (London, England)|October 9, 2002
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082Christine Katlama, Guislaine Carcelain, Claudine Duvivier, et al.The Journal of Experimental Medicine|June 22, 2005
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus diseaseKarim Sacre, Guislaine Carcelain, Nathalie Cassoux, et al.Oncotarget|March 8, 2016
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Vincent Vieillard, Shahin Gharakhanian, Olivier Lucar, et al.Bulletin De L'Academie Nationale De Medecine|March 26, 2015
[Towards eradication of human immunodeficiency virus (HIV)?]Christine KatlamaImmunological Reviews|June 19, 2013
Immune interventions in HIV infectionGuislaine Carcelain, Brigitte AutranAIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humansAnnika Vogt, Brice Mahé, Dominique Costagliola, et al.Pageof 50